Use of a predictive protocol to measure the antimicrobial resistance risks associated with biocidal product usage

Wesgate, Rebecca, Grasha, Pierre and Maillard, Jean Yves ORCID: https://orcid.org/0000-0002-8617-9288 2016. Use of a predictive protocol to measure the antimicrobial resistance risks associated with biocidal product usage. American Journal of Infection Control 44 (4) , pp. 458-464. 10.1016/j.ajic.2015.11.009

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (571kB) | Preview

Abstract

Background In this study we assessed the propensity of biocide exposure in the development of antimicrobial resistance in bacteria. Methods Our protocol is based on reporting changes in established antimicrobial susceptibility profiles in biocides and antibiotics after during use exposure to a product. The during use exposure reflects worse conditions of product use during application. It differs from the term low concentration, which usually reflects a concentration below the minimal inhibitory concentration, but not necessarily a concentration that occurs in practice. Results Our results showed that exposure to triclosan (0.0004%) was associated with a high risk of developing resistance and cross-resistance in Staphylococcus aureus and Escherichia coli. This was not observed with exposure to chlorhexidine (0.00005%) or a hydrogen peroxide–based biocidal product (in during use conditions). Interestingly, exposure to a low concentration of hydrogen peroxide (0.001%) carried a risk of emerging resistance to antibiotics if the presence of the oxidizing agent was maintained. We observed a number of unstable clinical resistances to antibiotics after exposure to the cationic biocide and oxidizing agent, notably to tobramycin and ticarcillin–clavulanic acid. Conclusions Using a decision tree based on the change in antimicrobial susceptibility test results, we were able to provide information on the effect of biocide exposure on the development of bacterial resistance to antimicrobials. Such information should address the call from the U.S. Food and Drug Administration and European Union Biocidal Products Regulation for manufacturers to provide information on antimicrobial resistance and cross-resistance in bacteria after the use of their product.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
Subjects:	Q Science > QR Microbiology
Additional Information:	Available online 22 January 2016 This is an open access article under the CC BY-NC-ND license
Publisher:	Elsevier
ISSN:	0196-6553
Date of First Compliant Deposit:	30 March 2016
Date of Acceptance:	5 November 2015
Last Modified:	05 May 2023 10:43
URI:	https://orca.cardiff.ac.uk/id/eprint/86234

Citation Data

Cited 51 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item